[{"id":"398de438-177f-4245-b03c-2ec81312578c","acronym":"","url":"https://clinicaltrials.gov/study/NCT02715882","created_at":"2021-01-18T13:16:56.079Z","updated_at":"2024-07-02T16:37:25.815Z","phase":"Phase 2","brief_title":"Clinical Study of Safety and Tolerability of CBLB502 as a Neo-adjuvant Treatment in Patients With Colorectal Cancer","source_id_and_acronym":"NCT02715882","lead_sponsor":"BioLab 612 LLC","biomarkers":" IL6 • CXCL8 • IL10","pipe":"","alterations":" ","tags":["IL6 • CXCL8 • IL10"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e entolimod (STAT-600)"],"overall_status":"Unknown status","enrollment":" Enrollment 40","initiation":"Initiation: 11/01/2015","start_date":" 11/01/2015","primary_txt":" Primary completion: 02/01/2017","primary_completion_date":" 02/01/2017","study_txt":" Completion: 12/31/2017","study_completion_date":" 12/31/2017","last_update_posted":"2017-02-09"}]